As of 2026-07-21, the Relative Valuation of Arrowhead Pharmaceuticals Inc (ARWR) is 41.97 USD. This relative valuation is based on P/E multiples. With the latest stock price at 71.65 USD, the upside of Arrowhead Pharmaceuticals Inc based on Relative Valuation is -41.4%.
The range of the Relative Valuation is 36.04 - 47.91 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 72.6x - 96.4x | 84.5x |
| Fair Price | 36.04 - 47.91 | 41.97 |
| Upside | -49.7% - -33.1% | -41.4% |
| Date | P/E |